InsidersTradesSigma
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by LALANDE KEVIN M., Director. Officer active across 3 companies, notably LUMOS PHARMA, INC.. Aggregated, 17 reports have been recorded. Total volume traded: €2m. The latest transaction was disclosed on 13 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations17 total
€87,373100,000 shares@ €0.8737100.0% of flow
Common Stock
SEC:0001209191-22-038477:0·
Ideal exit: 10 Mar 2023 (T+270)
€94,86010,000 shares@ €9.48610.1% of flow
Common Stock
SEC:0001126234-21-000141·
Ideal exit: 5 Jun 2022 (T+270)
€94,86010,000 shares@ €9.48610.1% of flow
Common Stock
SEC:0001126234-21-000141:0·
Ideal exit: 5 Jun 2022 (T+270)
€59,5626,300 shares@ €9.45436.3% of flow
Common Stock
SEC:0001126234-21-000138·
Ideal exit: 30 May 2022 (T+270)
€59,5626,300 shares@ €9.45436.3% of flow
Common Stock
SEC:0001126234-21-000138:0·
Ideal exit: 30 May 2022 (T+270)
€76,9168,625 shares@ €8.91788.2% of flow
Common Stock
SEC:0001126234-21-000133·
Ideal exit: 27 May 2022 (T+270)
€76,9168,625 shares@ €8.91788.2% of flow
Common Stock
SEC:0001126234-21-000133:0·
Ideal exit: 27 May 2022 (T+270)
€124,91314,900 shares@ €8.383413.3% of flow
Common Stock
SEC:0001126234-21-000129·
Ideal exit: 22 May 2022 (T+270)
€124,91314,900 shares@ €8.383413.3% of flow
Common Stock
SEC:0001126234-21-000129:0·
Ideal exit: 22 May 2022 (T+270)
€266,89135,679 shares@ €7.480328.4% of flow
Common Stock
SEC:0001126234-21-000123·
Ideal exit: 17 May 2022 (T+270)
€266,89135,679 shares@ €7.480328.4% of flow
Common Stock
SEC:0001126234-21-000123:0·
Ideal exit: 17 May 2022 (T+270)
€115,67016,000 shares@ €7.229412.3% of flow
Common Stock
SEC:0001126234-21-000117·
Ideal exit: 14 May 2022 (T+270)
€115,67016,000 shares@ €7.229412.3% of flow
Common Stock
SEC:0001126234-21-000117:0·
Ideal exit: 14 May 2022 (T+270)
€199,32431,000 shares@ €6.429821.2% of flow
Common Stock
SEC:0001126234-21-000115·
Ideal exit: 9 May 2022 (T+270)
€199,32431,000 shares@ €6.429821.2% of flow
Common Stock
SEC:0001126234-21-000115:0·
Ideal exit: 9 May 2022 (T+270)
0367 shares0
Common Stock
SEC:0001126234-21-000080·
0367 shares0
Common Stock
SEC:0001126234-21-000080:0·
17 of 17 declarations
About LALANDE KEVIN M.
Kevin M. Lalande is an insider at Lumos Pharma, Inc.
